•
Sep 30, 2020

Lyell Immunopharma Q3 2020 Earnings Report

Total Revenue
$1.07M
EPS
-$0.169
R&D Expenses
$24.5M
G&A Expenses
$13.6M
Gross Profit
$1.07M

Lyell Immunopharma

Lyell Immunopharma